Immunobiology of IL-37: Mechanism of action and clinical perspectives

Expert Review of Clinical Immunology

Volumn 10, Issue 12, 2014, Pages 1703-1709

  Quirk, Shannon ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive immunity; Autoimmune disease; IL 37; Inflammation; Innate immunity

Indexed keywords

BIOLOGICAL MARKER; COLONY STIMULATING FACTOR 1; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 32; INTERLEUKIN 37; INTERLEUKIN 37 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IL37 PROTEIN, HUMAN; INTERLEUKIN 1;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CELL DEATH; CHRONIC INFLAMMATION; CONTACT ALLERGY; CROHN DISEASE; DENDRITIC CELL; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; GENETICS; GUILLAIN BARRE SYNDROME; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOBIOLOGY; INNATE IMMUNITY; LIVER DISEASE; LIVER ISCHEMIA; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; INFLAMMATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INFLAMMATION; INTERLEUKIN-1;

EID: 84911092624     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2014.971014     Document Type: Review

References (28)

1. Dinarello CA, Arend W, Sims J, et al. IL-1 family nomenclature. Nat Immunol 2010; 11 (11): 973
2. Nold MF, Nold-Petry CA, Zepp JA, et al. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11 (11): 1014-24
3. Boraschi D, Lucchesi D, Hainzl S, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22 (3): 127-47
4. Luo Y, Cai X, Wang S, et al. IL-37 suppresses contact hypersensitivity by inducing tolerogenic dendritic cells. Cytokine 2013; 63:283
5. Dinarello CA, Bufler P. Interleukin-37. Semin Immunol 2013; 25 (6): 466-8
6. Kumar S, Hannin CR, Brigham-Burke MR, et al. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine 2002; 18 (2): 61-71
7. Bufler P, Azam T, Gamboni-Robertson F, et al. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc Natl Acad Sci USA 2002; 99 (21): 13723-8
8. Nold MF, Nold-Petry CA, Lo C, et al. Interleukin 37 employs the IL-1 family inhibitory receptor SIGIRR and the alpha chain of the IL-18 receptor to suppress innate immunity. Cytokine 2013; 63: 287
9. Bufler P, Gamboni-Robertson F, Azam T, et al. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J 2004; 381 (1): 503-10
10. Sharma S, Kulk N, Nold MF, et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 2008; 180 (8): 5477-82
11. Bulau A-M, Gruschka A, Schwaiger R, et al. Anti-IL-37 antibody abrogates the protection in IL-37 transgenic mice to LPS-induced septic shock. Cytokine 2013; 63 (3): 250
12. Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2011; 127 (3):e1-e70 701-21
13. Teng X, Hu Z, Wei X, et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing pro-inflammatory cytokine production. J Immunol 2014; 192(1): 1815-23
14. Harskamp CT, Armstrong AW. Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies. Semin Cutan Med Surg 2013;32 (3): 132-9
15. McNamee EN, Masterson JC, Jedlicka P, et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 2011; 108 (40): 16711-16
16. Imaeda H, Takahashi K, Fujimoto T, et al. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol 2013; 172(3): 410-16
17. Song L, Qiu F, Fan Y, et al. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol 2013; 33 (1): 111-17
18. Li C, Zhao P, Xiguang S, et al. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré Syndrome. Mediat Inflamm 2013; 8 (1): 1-9
19. Moschen AR, Molnar C, Enrich B, et al. Adipose and liver expression of IL-1 family members in morbid obesity and effects of weight loss. Mol Med 2011; 17 (7- 8): 840-5
20. Bulau A-M, Fink M, Maucksch C, et al. In vivo expression of Interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. Sci World J 2011; 11 (1): 2480-90
21. Sakai N, Van Sweringen HL, Belizaire RM, et al. Interluekin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 2012; 27 (10): 1609-16
22. Li C, Ji HF, Cai YJ, et al. Serum Interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. J Interferon Cytokine Res 2013; 33 (10): 612-18
23. Ji Q, Zeng Q, Huang Y, et al. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. Mediat Inflamm 2014; 3 (1): 1-9
24. Smith DE, Renshaw BR, Ketchem RR, et al. Four new members expand the interleukin-1 superfamily. J Biol Chem 2000; 275 (2): 1169-75
25. Kumar S, McDonnell PC, Lehrt R, et al. Identification and initial characterization of four novel members of the Interleukin-1 family. J Biol Chem 2000; 275 (4): 10308-14
26. Busfield SJ, Comrack CA, Yu G, et al. Identification and gene organization of three novel members of the IL-1 family on human chromosome 2. Genomics 2000; 66 (1): 213-16
27. Pan G, Risser P, Mao W, et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-Rrp. Cytokine 2001; 13 (1): 1-7
28. Ji Q, Zeng Q, Huang Y, et al. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome. Mediat Inflamm 2014; 3 (1): 1-9